We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Therapeutic Goods Act 1989
I, Dr Larry Kelly, Co-ordinator, Monitoring and Compliance Group, Therapeutic Goods Administration and delegate of the Secretary to the Department of Health and Ageing for the purposes of section 42DF(1) of the Therapeutic Goods Act 1989, give notice that the restricted representation described in paragraph (a) below has been approved for use in advertisements directed to consumers, for the products identified in paragraph (b) provided the conditions identified in paragraph (c) are met:
- Representations to the effect that advertisements to consumers for the goods described in paragraph (b) may refer to: "diabetes".
- Colgate Total Advanced Clean (Aust R 163301), Colgate Total Advanced Fresh (Aust R 154434), Colgate Total Whitening (Aust R 154433), Colgate Total (Aust R 154432) and Colgate Total Mint Stripe (Aust R 154430) supplied as a medicine by Colgate-Palmolive Pty Ltd.
- The claims made in the advertisements must not extend beyond their intended purpose on the Australian Register of Therapeutic Goods. The advertisements in which the representations are made must comply with the Therapeutic Goods Advertising Code 2007, as amended from time to time, and must advise consumers to seek advice from their medical practitioner or health care professional.
Dated this 4th day of February 2011
Dr Larry Kelly
Delegate of the Secretary to the Department of Health and Ageing; and
Co-ordinator
Monitoring and Compliance Group